A Prospective Randomized Study of Acyclovir Versus Ganciclovir Plus Human Immune Globulin Prophylaxis of Cytomegalovirus Infection After Solid Organ Transplantation1,2

Dünn, David L.; Gillingham, Kristen J.; Kramer, M. R.; Schmidt, Walter; Erice, Alejo; Balfour, Henry H.; Gores, P. F.; Gruessner, Rainer W.G.; Matas, Arthur J.; Payne, William D.; Sutherland, David E.R.; Najarían, John S.

doi:10.1097/00007890-199403270-00019

Cited by 72 publications

(20 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The optimal prophylaxis against CMV infection after solid organ transplantation has been controversial, and several different combinations of ganciclovir, both intravenous and oral; oral acyclovir; and human anti-CMV immunoglobulin have been described with varying effectiveness. [12][13][14][15][16] We used a short course of intravenous ganciclovir followed by high-dose oral acyclovir for 3 months without regard to serological status. Our incidence of invasive CMV disease was only 14%.…”

Section: Discussionmentioning

confidence: 99%

Infectious complications after OKT3 induction in liver transplantation

1997

View full text Add to dashboard Cite

The present study examines the incidence, risk factors, bacteriology, and mortality of infectious episodes and the role of antimicrobial prophylactic regimens after OKT3 induction in liver transplantation. Infections occurring in the first 6 months were evaluated according to the Centers for Disease Control criteria in 102 transplant recipients. Patients were administered OKT3 for 5 to 10 days, beginning intraoperatively, azathioprine, low-dose prednisone, and delayed introduction of cyclosporine. There were 140 major and 30 minor infections for an incidence of 1.7 infections per patient. Twenty-seven patients (26%) had no infectious episodes during the 6 months of followup. Bacterial and fungal infections peaked during the first month posttransplantation, whereas viral infections peaked during the second month. Infection-related mortality was 10%. One-year survival rate of patients who suffered a major infection was less than those who were infection free, but the difference was not statistically significant (79% vs. 89%; P ‫؍‬ .61). There was a significantly higher incidence of enterococcal infections under cefotetan prophylaxis than under ampicillinsulbactam (.375 vs. 11 infections per patient; P ‫؍‬ .0017). There were 14 episodes of cytomegalovirus disease (14%) but no cytomegalovirusrelated mortality or graft loss, and all cases responded to ganciclovir treatment. Bivariate and multivariate analyses identified only retransplantation as a risk factor for infection. In conclusion, OKT3 induction after liver transplantation is associated with a manageable incidence of bacterial, viral, or fungal infections. This is caused by, at least in part, improved anti-infective prophylaxis. Copyright 1997 by the American Association for the Study of Liver Diseases I t has been a central tenet in transplantation that any therapy that decreases the likelihood of acute rejection is likely to be accompanied by a corresponding increase in the likelihood of infection. A prime example of this paradigm has been the use of the monoclonal antibody OKT3 to treat steroid-resistant rejection. Although extraordinarily effective in reversing established rejections, the use of OKT3 in these circumstances has been accompanied by an increase in the prevalence of infections, especially those of viral etiology. 1 In contrast, small, randomized comparative studies of OKT3 as induction immunotherapy vs. cyclosporine therapy have not documented an increase in infections with the use of OKT3 in this setting but have shown immunologic advantages such as a 20%-40% decrease in the incidence of acute rejection. 2-5 A detailed examination of infections in liver transplant recipients receiving OKT3 induction has not been published. Therefore, we reviewed an unselected cohort of 102 patients undergoing primary orthotopic liver transplantation to determine the incidence of bacterial, fungal, and viral infections after OKT3 induction, including type, frequency, and risk factors of infections as well as the impact of antimicrobial prophylaxis on the infe...

show abstract

Section: Discussionmentioning

confidence: 99%

Infectious complications after OKT3 induction in liver transplantation

1997

View full text Add to dashboard Cite

show abstract

“…remains to be studied. Of concern is the recent observation that ganciclovir for 1 week combined with human immunoglobulin was less effective than high dose acyclovir in a large randomized trial of organ transplant patients (predominantly renal transplant patients) at the University of Minnesota (36).…”

Section: Discussionmentioning

confidence: 99%

A Prospective Randomized Trial Comparing Sequential Ganciclovir-High Dose Acyclovir to High Dose Acyclovir for Prevention of Cytomegalovirus Disease in Adult Liver Transplant Recipients

Martin¹,

Máñez²,

Linden³

et al. 1994

Transplantation

View full text Add to dashboard Cite

show abstract

“…Current prophylactic approaches vary widely among different transplant programs (5,8,18,26,72,104,105,143,145,172,232,236,273,284,299,319,382,396,423,497) (Table 5). Reasons for the discrepancies reflect the absence of large, multicenter, randomized trials evaluating the efficacy of countless preventive strategies.…”

Section: Specific Antiviral Prophylaxismentioning

confidence: 99%